JESSIAN MUNOZ to Humans
This is a "connection" page, showing publications JESSIAN MUNOZ has written about Humans.
Connection Strength
0.692
-
4-French Aortic Balloon Occlusion in Cesarean Hysterectomy for Placenta Accreta Spectrum Disorder. Obstet Gynecol. 2025 Jun 01; 145(6):732-738.
Score: 0.027
-
Conservative management of placenta accreta spectrum is associated with improved surgical outcomes compared to cesarean hysterectomy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025 May; 232(5):432-452.e3.
Score: 0.026
-
Surgical Outcomes and Associated Morbidity of Active and Expectant Management of Second-Trimester Placenta Accreta Spectrum (PAS). Medicina (Kaunas). 2025 Jan 14; 61(1).
Score: 0.026
-
Clinical Characteristics and Outcomes of Intrauterine Blood Transfusion (IUT) for Infectious Etiologies. Prenat Diagn. 2024 12; 44(13):1622-1627.
Score: 0.026
-
Mental Health Assessments for Fetal Interventions. J Clin Psychiatry. 2024 Jun 24; 85(3).
Score: 0.025
-
Risk factors for intensive care unit admission after cesarean hysterectomy for placenta accreta spectrum. Int J Gynaecol Obstet. 2024 Nov; 167(2):656-662.
Score: 0.025
-
Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum. Medicina (Kaunas). 2024 Apr 22; 60(4).
Score: 0.025
-
Perinatal outcomes of fetoscopic selective laser photocoagulation for spontaneous twin-anemia polycythemia sequence. Prenat Diagn. 2024 07; 44(8):965-970.
Score: 0.025
-
Outcomes of fetal lower urinary tract obstruction based on?timing of oligohydramnios onset. Prenat Diagn. 2024 02; 44(2):131-137.
Score: 0.024
-
Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2024 Feb; 293:32-35.
Score: 0.024
-
An obstetric-specific surgical Apgar score predicts maternal morbidity from cesarean hysterectomy for placenta accreta spectrum. Int J Gynaecol Obstet. 2024 Mar; 164(3):912-917.
Score: 0.024
-
Risk of Severe Maternal Morbidity in Patients with Placenta Accreta Spectrum Disorders Referred from Rural Communities to a Regional Placenta Accreta Spectrum Center. Am J Perinatol. 2023 12; 40(16):1738-1744.
Score: 0.024
-
Factors Limiting Magnetic Resonance Imaging Diagnosis of Placenta Accreta Spectrum. Am J Perinatol. 2023 10; 40(13):1398-1405.
Score: 0.023
-
Preterm birth and foetal-neonatal death rates associated with the Affordable Care Act Medicaid expansion (2014-19). J Public Health (Oxf). 2023 03 14; 45(1):99-101.
Score: 0.023
-
Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies. J Matern Fetal Neonatal Med. 2022 Dec; 35(26):10692-10697.
Score: 0.023
-
Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS). Gynecol Oncol. 2022 09; 166(3):460-464.
Score: 0.022
-
Correlation of clinical outcomes with the application of the 2020 consensus panel on histological classification for Placenta Accreta Spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):10044-10048.
Score: 0.022
-
Effect of anesthesia selection on neonatal outcomes in cesarean hysterectomies for placenta accreta spectrum (PAS). J Perinat Med. 2022 Nov 25; 50(9):1210-1214.
Score: 0.022
-
Short interval pregnancy is associated with pathology severity in placenta accreta spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):8863-8868.
Score: 0.021
-
Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):8640-8644.
Score: 0.021
-
Whole blood transfusion reduces overall component transfusion in cases of placenta accreta spectrum: a pilot program. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):6455-6460.
Score: 0.020
-
Antenatal ultrasound compared to MRI evaluation of fetal myelomeningocele: a prenatal and postnatal evaluation. J Perinat Med. 2019 Sep 25; 47(7):771-774.
Score: 0.018
-
Fetal thyroid disorders: Pathophysiology, diagnosis and therapeutic approaches. J Gynecol Obstet Hum Reprod. 2019 Apr; 48(4):231-233.
Score: 0.017
-
Vulvovaginitis: Find the cause to treat it. Cleve Clin J Med. 2017 Mar; 84(3):215-224.
Score: 0.015
-
Sequential Amniotic Fluid Thyroid Hormone Changes Correlate with Goiter Shrinkage following in utero Thyroxine Therapy. Fetal Diagn Ther. 2016; 39(3):222-7.
Score: 0.014
-
Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells. Cancer Lett. 2015 Oct 10; 367(1):69-75.
Score: 0.014
-
Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level. Oncotarget. 2015 Jan 20; 6(2):1190-201.
Score: 0.013
-
Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells. Mol Cancer Ther. 2014 Oct; 13(10):2399-411.
Score: 0.013
-
Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs. Differentiation. 2012 Sep; 84(2):214-22.
Score: 0.011
-
Prediction of survival in fetuses with left-sided congenital diaphragmatic hernia: Which method is better using MRI observed to expected total fetal lung volumes? Eur J Obstet Gynecol Reprod Biol. 2025 Apr; 307:241-246.
Score: 0.007
-
Neurodevelopmental Outcomes after Fetoscopic Myelomeningocele Repair. J Pediatr. 2025 Apr; 279:114472.
Score: 0.007
-
Adverse outcomes in monochorionic twins with amniotic fluid abnormalities without TTTS: A Case-Control study. Eur J Obstet Gynecol Reprod Biol. 2025 Mar; 306:132-138.
Score: 0.007
-
Risk of Genetic Abnormality in Fetuses With Unilateral Versus Bilateral Pleural Effusions. Prenat Diagn. 2024 10; 44(11):1296-1303.
Score: 0.006
-
Suture Characteristics after Exposure to Amniotic Fluid from an in vitro Model of Fetal Surgery. Fetal Diagn Ther. 2024; 51(5):463-473.
Score: 0.006
-
Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum care. Am J Obstet Gynecol MFM. 2024 01; 6(1):101229.
Score: 0.006
-
Impact of Race/Ethnicity and Insurance Status on Obstetric Outcomes: Secondary Analysis of the NuMoM2b Study. Am J Perinatol. 2024 05; 41(S 01):e2907-e2918.
Score: 0.006
-
Impact of Transfer of Maternal Care for Fetal Anomalies on Maternal Depression and Anxiety Screening: A Prospective Cohort at a Tertiary Care Center. Fetal Diagn Ther. 2023; 50(4):282-288.
Score: 0.006
-
Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review. Prenat Diagn. 2023 05; 43(5):687-698.
Score: 0.006
-
Effects of delayed cord clamping on neonatal hyperbilirubinemia in pre-gestational diabetes at term. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):7267-7275.
Score: 0.005
-
Surgical site infection after cesarean delivery: incidence and risk factors at a US academic institution. J Matern Fetal Neonatal Med. 2018 Jul; 31(14):1873-1880.
Score: 0.004
-
The bone marrow niche in support of breast cancer dormancy. Cancer Lett. 2016 09 28; 380(1):263-71.
Score: 0.003
-
Exogenous CXCL12 activates protein kinase C to phosphorylate connexin 43 for gap junctional intercellular communication among confluent breast cancer cells. Cancer Lett. 2013 Apr 30; 331(1):84-91.
Score: 0.003
-
Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells. Clin Transl Sci. 2011 Oct; 4(5):380-6.
Score: 0.003
-
Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish. Stem Cells Dev. 2012 Jan 20; 21(2):308-20.
Score: 0.003
-
Loss of RE-1 silencing factor in mesenchymal stem cell-derived dopamine progenitors induces functional maturity. Mol Cell Neurosci. 2008 Oct; 39(2):285-90.
Score: 0.002
-
Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz). 2008 Jan-Feb; 56(1):1-8.
Score: 0.002